URESE

Pre-Launch

benzthiazide

NDAORALTABLET
Lifecycle
Pre-Launch
Clinical Trials
11

Clinical Trials (5)

NCT05489744Phase 1Completed

Human Mass Balance and Biotransformation Study of [14C]Afuresertib

Started Aug 2022
6 enrolled
Healthy Volunteer
NCT05383482Phase 1/2Completed

Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1

Started Jul 2022
22 enrolled
Solid TumorNSCLCCervical Cancer+3 more
NCT04851613Phase 3Recruiting

Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer

Started Feb 2022
256 enrolled
Breast Cancer
NCT04374630Phase 2Completed

Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian

Started Jun 2020
150 enrolled
Platinum-resistant Ovarian Cancer
NCT04060394Phase 1/2Completed

Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC

Started Sep 2019
49 enrolled
Metastatic Castration-resistant Prostate Cancer